Data in motion
Pfizer, a titan in the pharmaceutical industry, has been at the forefront of medical innovation for decades. This chart highlights the top 10 Pfizer clinical trials by enrollment, showcasing the company's commitment to advancing healthcare. These trials, spanning various therapeutic areas, reflect Pfizer's strategic focus on large-scale studies to ensure robust data and reliable outcomes.
In recent years, Pfizer's trials have seen a significant increase in participant numbers, with some studies enrolling over 20% more participants than previous years. This surge underscores the growing trust in Pfizer's research capabilities and the global demand for cutting-edge treatments.
While the data provides a comprehensive overview, it's important to note that some trials have missing values, which could impact the overall interpretation. Nevertheless, Pfizer's dedication to innovation remains unwavering, promising a healthier future for all.
Total Enrollment in Phase I, II, and III for the Year 2024
Enrollment trend in studies over the years
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Trend of Clinical Trials Over the Last 10 Years
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years
Comparison of Clinical Trials in Canada vs United States Over the Years
Count of Oncology Trials Starting in the Next 3 Months
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Top 10 Recent Clinical Trials by Completion Date